Ameritas Investment Partners’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$166K Buy
6,671
+963
+17% +$24.9K 0.01% 1385
2025
Q4
$145K Hold
5,708
﹤0.01% 1470
2025
Q3
$92K Sell
5,708
-1,268
-18% -$20.5K ﹤0.01% 1741
2025
Q2
$112K Buy
6,976
+904
+15% +$13.7K ﹤0.01% 1679
2025
Q1
$104K Hold
6,072
﹤0.01% 1676
2024
Q4
$150K Buy
6,072
+487
+9% +$13.8K ﹤0.01% 1503
2024
Q3
$159K Hold
5,585
0.01% 1480
2024
Q2
$147K Hold
5,585
0.01% 1469
2024
Q1
$180K Hold
5,585
0.01% 1354
2023
Q4
$235K Buy
5,585
+224
+4% +$8.24K 0.01% 1161
2023
Q3
$206K Buy
5,361
+905
+20% +$20.5K 0.01% 1153
2023
Q2
$84.5K Buy
4,456
+1,315
+42% +$24.5K ﹤0.01% 1711
2023
Q1
$48.7K Hold
3,141
﹤0.01% 1998
2022
Q4
$55.9K Hold
3,141
﹤0.01% 1987
2022
Q3
$17K Hold
3,141
﹤0.01% 2597
2022
Q2
$12K Hold
3,141
﹤0.01% 2782
2022
Q1
$17K Hold
3,141
﹤0.01% 2622
2021
Q4
$27K Hold
3,141
﹤0.01% 2497
2021
Q3
$27K Hold
3,141
﹤0.01% 2531
2021
Q2
$33K Hold
3,141
﹤0.01% 2448
2021
Q1
$50K Hold
3,141
﹤0.01% 2084
2020
Q4
$145K Buy
3,141
+166
+6% +$7.67K 0.01% 1332
2020
Q3
$105K Buy
2,975
+1,287
+76% +$38.7K ﹤0.01% 1393
2020
Q2
$41K Buy
+1,688
New +$36.2K ﹤0.01% 1949

Other funds holding IMVT